The researchers, Xueneng Yang, Ruijuan Li, and Wendong Luo, quantified inequality using the slope index of inequality (SII) and the concentration index (CI). Countries were ranked from lowest to highest according to the socio-demographic index (SDI), a composite measure combining per capita income, educational attainment, and total fertility rate. The SII, estimated through population-weighted regression, expresses the absolute difference in disease burden between the most and least developed settings, while the CI, which ranges from −1 to +1, indicates whether disease burden is concentrated among low-SDI or high-SDI countries. Negative values in both measures signal that the burden falls disproportionately on the poorest nations—a pattern that dominated the study’s findings.

In 2021, the global disability-adjusted life year (DALY) rate—a measure combining years of life lost to premature death with years lived in poor health—stood at 22,377.4 per 100,000 people of reproductive age, with males shouldering a heavier burden (23,789.15) than females (20,928.80). Non-communicable diseases remained the dominant category at 13,109.2 DALYs per 100,000, followed by communicable, maternal, neonatal, and nutritional diseases and injuries. At the more granular level, COVID-19, road injuries, and depressive disorders ranked among the top causes, while migraine, major depressive disorder, and self-harm led the level-four classification—evidence that mental health and chronic pain now weigh as heavily on this age group as the infectious threats of previous decades.

The headline finding is that overall socioeconomic health inequality declined between 1990 and 2021. The SII for all causes moved from −17,755.23 to −13,789.27, and the CI improved from −0.15 to −0.13, meaning the gap in disease burden between the most and least developed countries shrank in both absolute and relative terms. A sensitivity analysis using 2019 as a pre-pandemic endpoint confirmed the pattern, and a population-weighted Gini index—which measures between-country differences without relying on socioeconomic ranking—showed a similarly stable trajectory from 0.15 in 1990 to approximately 0.15 in 2021, after dipping to 0.14 in 2019.

Beneath that aggregate improvement, however, the story diverges sharply by disease category. The most striking progress came in communicable, maternal, neonatal, and nutritional diseases: the SII nearly halved, from −15,690.50 to −9,571.89, with the CI improving from −0.51 to −0.38. Maternal and neonatal disorders showed a similar narrowing, as did neglected tropical diseases and malaria, where the SII fell from −2,982.90 to −762.83. These gains likely reflect decades of investment in vaccination campaigns, maternal health programs, and infectious disease control that have disproportionately benefited poorer countries—the populations with the most ground to make up.

Yet the study documents an ominous reversal elsewhere. Injuries, once nearly egalitarian in their distribution, saw their SII deteriorate from −344.35 to −1,686.57, with the CI worsening from −0.06 to −0.12, indicating that road accidents and other external causes of death and disability are now increasingly concentrated in lower-development settings. Transport injuries showed the same pattern, flipping from a slightly pro-rich gradient in 1990 to a strongly pro-poor one by 2021. HIV/AIDS and sexually transmitted infections followed a parallel course: although overall inequality in infectious disease narrowed, the SII for HIV/AIDS worsened from −266.82 to −1,040.78, and drug-susceptible tuberculosis remained among the most unequally distributed conditions in the entire analysis, with a CI of −0.59 in 2021. Cardiovascular disease inequality also deepened, with the SII nearly doubling to −918.87.

The analysis also carved the data by sex, revealing that socioeconomic gradients in disease are not gender-neutral. For maternal and neonatal disorders, the SII among females in 2021 was −2,029.05, compared with a negligible −22.38 among males—unsurprising given the biology, but a stark reminder of where the inequity burden lands. More telling are the subtler contrasts: males showed much steeper socioeconomic gradients for injuries (SII of −2,749.96 versus −824.23 for females), road injuries, self-harm, and several digestive conditions, while females showed greater gradients for cardiovascular disease, HIV/AIDS, nutritional deficiencies, anxiety disorders, and migraine. The authors are careful to frame these as descriptive differences in sex-specific socioeconomic gradients rather than direct measures of sex-based health inequity, noting that GBD 2021 reports sex as a binary category and cannot capture gender identity.

The authors ground these patterns in an ecosocial framework—the idea that people biologically embody their social and ecological circumstances across their life courses. At the structural level, policies on insurance coverage, education, housing, and wages determine who accesses care; the study cites mechanisms such as racial segregation in the Americas, which have been associated with elevated rates of tuberculosis and perinatal depression in minority communities. At the social level, poverty shapes living conditions, employment stability, and health literacy, which in turn constrain behaviors like diet, sleep, and substance use that are often mislabeled as purely personal choices. Gendered factors compound the picture: female symptoms are more frequently underestimated, women are less likely to receive advanced therapies such as heart failure treatment or liver transplantation, and pregnant women are routinely excluded from clinical trials, leaving evidence gaps on drug safety in pregnancy.

The policy implications are as layered as the causes. The authors argue that health equity should be a national policy objective pursued through cross-sector collaboration spanning finance, education, labor, and urban planning—not merely through health ministries alone. Community-level interventions such as health education, digital outreach, and local support networks can extend reach to marginalized groups, while individual-level tools like text-message reminders and visual prompts can nudge healthier decisions. Crucially, they call for improved health surveillance with stratified data and long-term tracking systems, so that interventions can be evaluated against the populations and diseases where inequality is persistent or worsening. For the reproductive-age population specifically, the stakes extend beyond this generation: the health of people aged 15 to 49 shapes fertility, child development, and demographic sustainability, making health equity in this cohort an investment in the intergenerational future rather than a cost. The study’s limitations—data quality in low- and middle-income countries, coarse age stratification, and a descriptive rather than causal design—suggest the next research frontier lies in longitudinal, individual-level data that can trace how social position becomes biology.

Subject of Research: Socioeconomic health inequality in disease burden among the global reproductive-age population, 1990–2021

Article Title: Health inequalities in the global reproductive-age population: GBD 2021 trends and female-male differences, 1990–2021

Article References: Yang, X., Li, R., & Luo, W. (2026). Health inequalities in the global reproductive-age population: GBD 2021 trends and female-male differences, 1990–2021. iScience, 29(11), Article 117804. https://doi.org/10.1016/j.isci.2026.117804

Image Credits: AI Generated

DOI: 10.1016/j.isci.2026.117804

Keywords: health inequality, Global Burden of Disease, reproductive-age population, DALY, socio-demographic index, slope index of inequality, concentration index, sex differences, non-communicable diseases, injuries, HIV/AIDS, health equity